ELVN Enliven Therapeutics, Inc. logo

ELVN Enliven Therapeutics, Inc.

Healthcare
$41.54-1.68%ClosedMarket Cap: $2.53B

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

127

13F Shares

62,307,228

Ownership %

100.3%

New Positions

21

Increased Positions

66

Closed Positions

28

Reduced Positions

44

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
XPH192,2972.40%
BBCVirtus Biotech Clinical Trials ETF16,1731.80%
FMEDFidelity Disruptive Medicine ETF17,1231.21%
CANCTema Oncology ETF42,7771.04%
KTD124,4060.47%
IHEiShares U.S. Pharmaceuticals ETF124,4060.47%
IJE99,1960.31%
IWCiShares Micro-Cap ETF99,1960.31%
IBBiShares Biotechnology ETF322,5560.15%
NLO319,6870.10%
IWOiShares Russell 2000 Growth ETF319,6870.10%
AVSCAvantis U.S. Small Cap Equity ETF55,3790.09%
ESMLiShares ESG Aware MSCI USA Small-Cap ETF43,8250.08%
VTWG36,0560.07%
DFASDimensional - US Small Cap ETF176,3870.05%
NJM966,2410.05%
IWMiShares Russell 2000 ETF966,2410.05%
SCHASchwab U.S. Small-Cap ETF215,2470.04%
RSSLGlobal X - Russell 2000 ETF17,9750.04%
VTWO195,0310.04%